Lundbeck Pharmaceuticals Italy SpA (acronym LUPI). LUPI is an independent business unit owned by the Danish pharmaceutical group H. Lundbeck A/S. The company offers a wide variety of chemical technologies such as: Handling of high toxic substances (cyanide, chlorine, liquid ammonia) - Strongly acidic chemistry (liquid SO3) - Chiral Separations, Chemical resolutions, Simulated Moving Bed (SMB) Chiral Chromatography - High vacuum conventional and thin film distillation - Grignard and other organometallics preparation - High (up to 300C) and low temperature (below -80C) reactions Main activities are: - Contract manufacturing - Production of APIs and Intermediates The company is regularly, successfully inspected by the Italian Ministry of Health, FDA and international authorities.
